Atlas Trials

A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Clinical trial NCT03254784 · COMPLETED

Trial details

NCT number
NCT03254784
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus ErythematosusArthritic PsoriasisPsoriasisInflammatory Bowel Diseases
Start date
2017-09-13
Primary completion
2017-11-04
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.